Literature DB >> 29103517

Stability and bioactivity of chitosan as a transfection agent in primary human cell cultures: A case for chitosan-only controls.

Tanya L Cupino1, Billy A Watson2, Alan C Cupino3, Keiji Oda3, Mark G Ghamsary4, Salvador Soriano5, Wolff M Kirsch6.   

Abstract

Chitosan polymers (Cs), from which microparticles (CsM) may be precipitated to deliver various intracellular payloads, are generally considered biologically inert. We examined the impact of cell culture conditions on CsM size and the effect of chitosan on CD59 expression in primary human smooth muscle cells. We found that particle concentration and incubation time in biological buffers augmented particle size. Between pH 7.0 and pH 7.5, CsM size increased abruptly. We utilized CsM containing a plasmid with a gene for CD59 (pCsM) to transfect cells. Both CD59 mRNA and the number of CD59-positive cells were increased after pCsM treatment. Unexpectedly, CsM also augmented the number of CD59-positive cells. Cs alone enhanced CD59 expression more potently than either pCSM or CsM. This observation strongly suggests that chitosan is in fact bioactive and that chitosan-only controls should be included to avoid misattributing the activity of the delivery agent with that of the payload.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD59; Chitosan; Gene delivery; Microparticle; Primary human cells

Mesh:

Substances:

Year:  2017        PMID: 29103517      PMCID: PMC5699233          DOI: 10.1016/j.carbpol.2017.10.021

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  37 in total

1.  Immunological effects and membrane interactions of chitosan nanoparticles.

Authors:  Aditya Pattani; Vandana B Patravale; Lata Panicker; Pravin D Potdar
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

2.  Chitosan oligosaccharides suppress production of nitric oxide in lipopolysaccharide-induced N9 murine microglial cells in vitro.

Authors:  Peng Wei; Pan Ma; Qing-Song Xu; Qun-Hua Bai; Jian-Guo Gu; Hao Xi; Yu-Guang Du; Chao Yu
Journal:  Glycoconj J       Date:  2012-05-24       Impact factor: 2.916

3.  Selective export of human GPI-anchored proteins from the endoplasmic reticulum.

Authors:  Carine Bonnon; Markus W Wendeler; Jean-Pierre Paccaud; Hans-Peter Hauri
Journal:  J Cell Sci       Date:  2010-04-27       Impact factor: 5.285

4.  Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(γ-glutamic acid) complexes as a gene delivery vector.

Authors:  Shu-Fen Peng; Michael T Tseng; Yi-Cheng Ho; Ming-Cheng Wei; Zi-Xian Liao; Hsing-Wen Sung
Journal:  Biomaterials       Date:  2011-01       Impact factor: 12.479

5.  Complementary DNA sequence and deduced peptide sequence for CD59/MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C.

Authors:  R Sawada; K Ohashi; K Okano; M Hattori; N Minato; M Naruto
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

6.  PGAP2 is essential for correct processing and stable expression of GPI-anchored proteins.

Authors:  Yuko Tashima; Ryo Taguchi; Chie Murata; Hisashi Ashida; Taroh Kinoshita; Yusuke Maeda
Journal:  Mol Biol Cell       Date:  2006-01-11       Impact factor: 4.138

7.  Acid-sensing ion channel 1 and nitric oxide synthase are in adjacent layers in the wall of rat and human cerebral arteries.

Authors:  Li-Hsien Lin; Jingwen Jin; Marcus B Nashelsky; William T Talman
Journal:  J Chem Neuroanat       Date:  2014-10-23       Impact factor: 3.052

8.  Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12.

Authors:  M Nahaei; H Valizadeh; B Baradaran; M R Nahaei; D Asgari; S Hallaj-Nezhadi; S Dastmalchi; F Lotfipour
Journal:  Drug Res (Stuttg)       Date:  2013-01-08

9.  Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles.

Authors:  Xiong Wei Li; Daniel Ken Lem Lee; Albert Sun Chi Chan; H Oya Alpar
Journal:  Biochim Biophys Acta       Date:  2003-10-20

10.  Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits.

Authors:  Edward K Agyare; Kristen M Jaruszewski; Geoffry L Curran; Jens T Rosenberg; Samuel C Grant; Val J Lowe; Subramanian Ramakrishnan; Anant K Paravastu; Joseph F Poduslo; Karunya K Kandimalla
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 11.467

View more
  1 in total

1.  Chitosan-miRNA functionalized microporous titanium oxide surfaces via a layer-by-layer approach with a sustained release profile for enhanced osteogenic activity.

Authors:  Kaimin Wu; Mengyuan Liu; Nan Li; Li Zhang; Fanhui Meng; Lingzhou Zhao; Min Liu; Yumei Zhang
Journal:  J Nanobiotechnology       Date:  2020-09-09       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.